Note de episod
This AI-generated conversation explores the challenges of implementing AI in pharma accurately, reliably and safely, particularly given the stringent requirements of good practice (GxP) regulations and the need to enhance trust among stakeholders, including regulatory authorities, healthcare professionals, and patients.
It is based on the BioPhorum publication Implementing AI systems in regulated pharma environments and key takeaways include:
• The whole AI lifecycle needs to be managed
• It's a risk-based approach with risk management throughout
• Setting clear objectives and scope…
Site: biophorum.com
